Vanderbilt Ingram Cancer Center

For more VICC news, visit their website »

Retro filtered photo of a couple sitting on wooden pier by lake.
November 9, 2017

Study to explore cancer survivorship, sexuality

Amid the intense discussions around head and neck cancer (HNC) treatment and survivorship planning, sexuality — an important quality of life issue — may understandably not be discussed. When and in what manner do patients with HNC want to talk about the impact the disease may have on their sexuality?

By VUMC News and Communications
November 9, 2017

Vanderbilt joins national neurofibromatosis network

The Vanderbilt-Ingram Cancer Center Neurofibromatosis (NF) Clinic has joined the Children’s Tumor Foundation NF Clinic Network.

By Tom Wilemon
November 3, 2017

Lung cancer survivors and caregivers invited to VUMC event Nov. 16

Lung cancer survivors and their caregivers are invited to attend a free educational evening at Vanderbilt University Medical Center (VUMC) Thursday, Nov. 16, 5:30 – 8:30 p.m., at the University Club, 2402 Garland Ave.

By VUMC News and Communications
November 2, 2017

Liquid biopsies help reveal lung cancer mutations

Cancer investigators led by researchers at Vanderbilt-Ingram Cancer Center (VICC) have co-developed a liquid biopsy blood-based assay used to identify specific gene mutations associated with the development or relapse of small-cell lung cancer (SCLC).

By VUMC News and Communications
(iStock)
October 26, 2017

Study to test combination therapy for breast cancer

Vanderbilt-Ingram Cancer Center (VICC) has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer.

By VUMC News and Communications
October 26, 2017

My Cancer Genome launches new search tool for clinical trials

Clinicians, investigators and cancer patients now have access to a new online search tool that provides more detailed information about clinical research trials available for cancer patients.

By VUMC News and Communications
October 26, 2017

New faculty: Tuya Pal, associate professor of medicine and Ingram Associate Professor of Cancer Research

A high school science class discussion about how genetic traits are passed down from one generation to another inspired Tuya Pal to pursue a career in clinical genetics. Pal is a physician who specializes in cancer health disparities among diverse populations.
By VUMC News and Communications
October 25, 2017

Vanderbilt-Ingram Cancer Center patients treated with new FDA-approved CAR T therapy

Vanderbilt-Ingram Cancer Center (VICC) has been selected as one of the few authorized treatment centers in the United States approved to administer the first FDA- approved chimeric antigen receptor T cell (CAR T) therapy for treatment of adult patients with a specific type of lymphoma. VICC is the only cancer center in a seven-state region of the Southeast authorized to deliver the new immunotherapy.
By VUMC News and Communications
October 19, 2017

Symposium honors Moses’ storied cancer research career

Members of the Vanderbilt University Medical Center (VUMC) community and others whose lives and careers have been influenced by legendary cancer investigator, educator and administrator Harold (Hal) Moses, M.D., have endowed the Linda and Harold L. Moses, M.D. Career Development Fund.
By VUMC News and Communications
October 18, 2017

Calcium intake and colorectal cancer

Calcium intake appears to protect against colorectal cancer in individuals with certain gene variants, Vanderbilt researchers have discovered.
By Leigh MacMillan
October 17, 2017

Researchers find novel mechanism of resistance to anti-cancer drugs

Vanderbilt investigators have discovered a novel non-genetic cause of resistance to the targeted anti-cancer therapy cetuximab. Their findings, reported this week in Nature Medicine, suggest a strategy for overcoming this resistance.
By Leigh MacMillan
October 6, 2017

The world beyond work: Lynetha Verge

She loves “Beauty and the Beast” and Disney World. Mornings—not so much.
By Dagny Stuart
September 28, 2017

VICC investigators land support from Komen Foundation

Three breast cancer investigators from Vanderbilt-Ingram Cancer Center (VICC) have been awarded research grants from Susan G. Komen, a nonprofit foundation devoted to supporting cancer research, community health outreach, advocacy and public policy initiatives.
By VUMC News and Communications
1 … 27 28 29 30 31 … 58